Ignite Creation Date:
2024-05-06 @ 3:53 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04797468
Status:
WITHDRAWN
Last Update Posted:
2023-01-17
First Post:
2021-03-04
Brief Title:
A Phase 1 Study of the CD73 InhibitorHLX23 Alone in Participants With Solid Tumor
Sponsor:
Shanghai Henlius Biotech
Organization:
Shanghai Henlius Biotech
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Solid Tumor |
Keywords: